|
COPD Clinical Trials
538 recruiting studies across 27 states and 47 cities.
Find Trials by State
Texas
81 trials · 7 cities
California
62 trials · 6 cities
Florida
57 trials · 4 cities
Arizona
38 trials · 3 cities
Pennsylvania
25 trials · 1 city
North Carolina
23 trials · 2 cities
Illinois
22 trials · 1 city
Maryland
21 trials · 1 city
New York
21 trials · 1 city
District of Columbia
21 trials · 1 city
Massachusetts
20 trials · 1 city
Ohio
18 trials · 2 cities
Colorado
15 trials · 1 city
Georgia
14 trials · 1 city
Oklahoma
13 trials · 2 cities
Missouri
11 trials · 1 city
Nevada
9 trials · 1 city
Tennessee
9 trials · 2 cities
Wisconsin
8 trials · 1 city
Minnesota
5 trials · 1 city
Nebraska
5 trials · 1 city
Washington
5 trials · 1 city
Virginia
5 trials · 1 city
Indiana
4 trials · 1 city
Oregon
4 trials · 1 city
Louisiana
2 trials · 1 city
New Mexico
1 trials · 1 city
Find Trials by City
Philadelphia, PA
25 trials
Chicago, IL
22 trials
Miami, FL
22 trials
Baltimore, MD
21 trials
New York, NY
21 trials
Washington, DC
21 trials
Boston, MA
20 trials
Houston, TX
18 trials
Long Beach, CA
17 trials
Los Angeles, CA
17 trials
Orlando, FL
17 trials
Arlington, TX
16 trials
Dallas, TX
16 trials
Mesa, AZ
16 trials
Phoenix, AZ
16 trials
Charlotte, NC
15 trials
Denver, CO
15 trials
Atlanta, GA
14 trials
Fort Worth, TX
13 trials
Tampa, FL
12 trials
Kansas City, MO
11 trials
Cleveland, OH
10 trials
San Antonio, TX
10 trials
San Jose, CA
10 trials
Las Vegas, NV
9 trials
Oklahoma City, OK
9 trials
San Francisco, CA
9 trials
Columbus, OH
8 trials
Milwaukee, WI
8 trials
Raleigh, NC
8 trials
Nashville, TN
7 trials
San Diego, CA
7 trials
El Paso, TX
6 trials
Jacksonville, FL
6 trials
Tucson, AZ
6 trials
Minneapolis, MN
5 trials
Omaha, NE
5 trials
Seattle, WA
5 trials
Virginia Beach, VA
5 trials
Indianapolis, IN
4 trials
Portland, OR
4 trials
Tulsa, OK
4 trials
Austin, TX
2 trials
Memphis, TN
2 trials
New Orleans, LA
2 trials
Sacramento, CA
2 trials
Albuquerque, NM
1 trials
Drugs Being Studied for COPD
Depemokimab3Tezepelumab3Tadalafil2BBT0022Lunsekimig2Dupilumab2Galvokimig1P63+ lung progenitors1HRS-9821 Powder for Inhalation1HSK39004 Placebo1HSK39004 Inhalation Suspension -3mg BID1HSK39004 Dry Powder Inhaler -1.5mg BID1HSK39004 Dry Powder Inhaler -0.75mg BID1EXPD-101/FXS7553 Dose 21EXPD-101/FXS7553 Dose 11HSK39004 Dry Powder Inhaler-0.75mg1HSK39004 Dry Powder Inhaler Simulant1Tozorakimab Dose Regimen 21Tozorakimab Dose Regimen 11VPV 500 mg1VPV 1000 mg1Eradication of Helcobacter Pylori1antibiotic treatments1Vaxigrip1
Recently Updated Trials
- STRIVE Post-Market Registry StudyOlympus Corporation of the Americas
- A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic BronchitisPhase 2UCB Biopharma SRL
- Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding DataCenter for Molecular Fingerprinting Research Nonprofit LLC
- Multi-Center Clean Air Randomized Controlled Trial in COPDPhase 3JHSPH Center for Clinical Trials
- 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of ExacerbationPhase 4Western University, Canada
- eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 InflammationPhase 3GlaxoSmithKline
- Unilateral vs. Bilateral Lung Volume Reduction SurgeryNARigshospitalet, Denmark
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseasePhase 2/Phase 3Pfizer
- Effectiveness of DITM Versus IMT in COPD PatientsNASir Run Run Shaw Hospital
- A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationPhase 4AstraZeneca
Frequently Asked Questions
How many COPD clinical trials are currently recruiting?
There are 538 COPD clinical trials currently recruiting participants across the United States.
Which states have the most COPD trials?
The states with the most COPD clinical trials are Texas, California, Florida.
What phases are COPD trials in?
COPD trials span multiple phases: NA (256), Not specified (175), Phase 2 (32).
Can healthy volunteers join COPD trials?
Most COPD trials require participants to have the condition. None of the currently recruiting trials explicitly accept healthy volunteers.
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.